Home › SRI International Announces PDCellX Xenograft Tumor Model Services To Accelerate Cancer Drug Research
 

Keywords :   


SRI International Announces PDCellX Xenograft Tumor Model Services To Accelerate Cancer Drug Research

2014-04-30 07:22:26| drugdiscoveryonline News Articles

SRI International has announced the availability of its PDCellX™ xenograft tumor model services for testing the activity of potential cancer therapeutics

Tags: services international research model

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
12.05Shein suppliers still work 75-hour weeks - report
12.05Is social media worth paying for?
12.05'I'm stuck in my flat due to 4k service charge'
12.05Switzer Ranch staying resilient with long-term outlook
12.05BIF announces Seedstock, Commercial Producer award finalists
11.05Weekly Recap: Hempel, Sherwin-Williams Top This Weeks Stories
11.05LG CHI Color Master Factory Is Awarded Patent
11.05AgriWebb raises $7.2m to fuel further innovation in sustainable beef production
More »